Yungjin Pharm. Co., Ltd. (KRX:003520)

Yungjin Pharm. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Jul 18, 2025	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Market Capitalization	416,995	287,744	348,135	150,622	145,500	92,268
Market Cap Growth	7.30%	-17.35%	131.13%	3.52%	57.69%	-33.17%
Enterprise Value	-	311,216	366,840	163,118	185,784	128,217
Last Close Price	2280.00	1620.00	1960.00	848.00	1091.83	692.38
PE Ratio	42.62	160.37	134.89	-	-	-
PS Ratio	2.63	2.09	3.11	1.30	1.41	0.83
PB Ratio	4.20	3.16	3.87	1.64	2.39	1.44
P/TBV Ratio	4.37	3.30	4.03	1.70	2.54	1.52
P/FCF Ratio	349.31	-	-	-	-	19.00
P/OCF Ratio	66.34	120.94	40.97	-	-	8.95
EV/Sales Ratio	-	2.26	3.27	1.40	1.80	1.16
EV/EBITDA Ratio	-	39.42	45.53	39.06	66.49	33.33
EV/EBIT Ratio	-	95.24	89.79	403.32	-	313.92
EV/FCF Ratio	-	-	-	-	-	26.40
Debt / Equity Ratio	0.28	0.27	0.31	0.35	0.77	0.63
Debt / EBITDA Ratio	1.94	3.16	3.46	7.68	16.85	10.47
Debt / FCF Ratio	23.51	-	-	-	-	8.30
Asset Turnover	0.94	0.86	-	-	0.74	0.89
Inventory Turnover	3.12	3.27	-	-	2.77	3.09
Quick Ratio	1.20	1.18	1.18	-	0.66	0.75
Current Ratio	2.06	1.95	1.86	-	1.44	1.48
Return on Equity (ROE)	9.00%	1.98%	2.84%	-3.02%	-6.96%	-10.51%
Return on Assets (ROA)	3.63%	1.28%	-	-	-0.29%	0.20%
Return on Capital (ROIC)	5.00%	1.75%	2.11%	0.22%	-0.38%	0.27%
Return on Capital Employed (ROCE)	7.40%	2.60%	3.40%	-	-	0.50%
Earnings Yield	2.05%	0.62%	0.74%	-1.53%	-2.99%	-6.34%
FCF Yield	0.29%	-0.27%	-1.53%	-	-2.50%	5.26%
Buyback Yield / Dilution	14.83%	-4.28%	-	-	-	-19.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.